CBD Forum by Chow420

Go back
Refer
$20
Refer
Get $20 in Chowcash when you refer friends, stores, and brands to Chow420. Your friends also get $20 towards their first purchase when they accept your invitation.
Login to Refer

Hemp News, Laws & Product Updates

A curated news hub focused on hemp regulation and policy changes, cannabinoids (CBD/Delta-8/Delta-9/hemp-derived THC), lab testing and COAs, product safety, brands, and industry trends.

  • Federal & State Hemp Laws
  • THC Policy
  • CBD / Delta-8
  • Compliance
  • Lab Testing (COA)
  • Product Safety
  • Industry & Brands
Back to Chow420
https://hightimes.com/

Does Smoking Weed Make You a Better Writer?

Earlier this month, my brother and I got tickets to see Argentina play against Canada in the Conmebol Copa America at Mercedes-Benz Stadium, and naturally we smoked a bit before heading over. Gorging on pulled pork and sipping cold cans of Stella Artois till our stomachs hurt, it didn’t take long for my mind to stop focusing on the game itself and start philosophizing about what sports events like this represented on an abstract level.  The sweaty players, tiny as ants from my viewpoint, struck me not as professional athletes but pretend hunter-gatherers pitted against each other in a fight for survival and victory that pushed their bodies to the limit. Conversely, the 70,000 or so people in the stands struck me not as spectators but alien overlords, watching the bloodbath in the way the ancient Romans would have watched gladiators battle in the Colosseum.  These overlords, I mused, were rather content with their having risen above the unforgiving state of nature, drowning themselves in food and drink while others fought for their lives for their amusement. But, so I imagined, they also felt ashamed, perhaps because they knew that – deep down – they were not living life the way human beings were supposed to, unlike those on the field.  I cringe a little when I look back at the misspelled notes I jotted down on my phone during halftime – but only a little. By and large, I tend to be quite happy with the stuff I write when I’m high. And I write high quite a lot. For years now, I’ve indulged in small amounts of weed whenever I’m working on challenging journalistic projects. Not only because it takes away some of the pressure I put on myself, helping me jump over sporadic bouts of writer’s block, but also because – and this is what I’ll try to argue in the following article – because there’s something about cannabis that, at least for me, really gets the writing juices flowing, allowing me to see the world in a new light, make astute observations, and put thoughts that would otherwise evade articulation into words.   I am, of course, far from the first writer-slash-journalist to flirt with marijuana. Victor Hugo, author of The Hunchback of Notre Dame and Les Misérables, belonged to a society of Parisian hashish aficionados. Hunter S. Thompson smoked copious amounts of cannabis, as did Truman Capote, and while I wouldn’t go as far as saying that substance use was the deciding factor in their literary success, I do think there is a reason that a magazine like High Times – which both these guys contributed to – was, for a long time, celebrated as one of the finest literary publications in America.  I still remember vividly the first time I realized the creative and analytical potential of cannabis. I was in bed watching Andrei Tarkovsky’s Solaris on MUBI. I had watched the film several times before during cinema studies classes at NYU, and was always bored senselessly. The famed Russian filmmaker was thoroughly avant-garde, telling his stories primarily through visuals rather than dialogue – a stark contrast to the explosive Hollywood blockbusters I grew up with. This time, with the help of a small joint, I finally felt I got it. Glued to my screen, images that had previously struck me as empty were suddenly filled with meaning. Sequences that previously seemed to take ages flew by in a heartbeat. Cannabis had opened my eyes to details I did not notice before. And now, I can’t unsee it.  Most people are shocked when I tell them I use weed to help me focus, rather than procrastinate. But it’s the truth, and I actually think it makes a lot of sense. Just as the average stoner forgets the world when they sit down for a big, fat, greasy meal or a tub of Ben & Jerry’s, so too does my field of vision shrink to the lines of text in front of me. My mental bandwidth shortened, I focus on a single task and become fully immersed in the story I’m writing.  And as I write, I stop thinking and start following the self-imposed rhythm of the words. The cliché is that good stories write themselves, and although this diminishes the role of the writer, I think there’s something to it – that writing, like painting or playing music or any other type of “art” – isn’t a constructive process so much as it’s one of discovery, the way some great sculptors say they are merely removing bits of marble to free the statue that already exists inside the block. Before marijuana, said the cannabis-loving author Norman Mailer, “I’d been someone who wrote for the sense of what I was saying.” After, “I began to write for the sound of what I was writing.”  While I don’t have the medical background to assess the scientific extent to which cannabis boosts creativity and perceptibility, I can – in my capacity as a journalist and critic – connect my own experiences to relevant concepts of literary theory. In his seminal essay “Art as Device,” the Russian scholar Viktor Shklovsky argued that great works of literature hinged on something he called “estrangement,” which can be loosely defined as an author’s ability to make the familiar unfamiliar, the old new, the ordinary extraordinary – the ability to, in short, describe something as though we are witnessing it for the first time.  To illustrate what he means with “estrangement,” Shklovsky referred to Kholstomer, a short story by the celebrated author Leo Tolstoy, written from the perspective of a horse, who sees the human world differently from humans. My personal go-to illustration of Shklovsky’s ideas is a different text, also by Tolstoy: the opening paragraph of his final novel Resurrection, which functions as a very literal wake-up call for readers to recognize and celebrate the beauty of the natural world – a beauty ruined by the trappings of modern civilization: “Though men in their hundreds of thousands had tried their hardest to disfigure that little corner of the earth where they had crowded themselves together, paving the ground with stones so that nothing could grow, weeding out every blade of vegetation, filling the air with the fumes of coal and gas, cutting down the trees and driving away every beast and every bird – spring, however, was still spring, even in the town. The sun shone warm, the grass, wherever it had not been scraped away, revived and showed green not only on the narrow strips of lawn on the boulevards but between the paving-stones as well, and the birches, the poplars and the wild cherry-trees were unfolding their sticky, fragrant leaves, and the swelling buds were bursting on the lime-trees; the jackdaws, the sparrows and the pigeons were cheerfully getting their nests ready for the spring, and the flies, warmed by the sunshine, buzzed gaily along the walls. All were happy – plants, birds, insects and children. But grown-up people – adult men and women – never left off cheating and tormenting themselves and one another. It was not this spring morning which they considered sacred and important, not the beauty of God’s world, given to all creatures to enjoy – a beauty which inclines the heart to peace, to harmony and to love. No, what they considered sacred and important were their own devices for wielding power over each other.” Tolstoy wasn’t the first to make this point. Mankind has heard it millions of times before, from spiritual scriptures to modern-day self help books. And yet, Tolstoy’s language and examples present it in an entirely new light, turning a tired cliché back into an original revelation, into a reminder of something we already knew, but which overexposure has caused us to forget in much the same way that we do not notice the tip of our own nose poking out between our eyes unless we pay express attention to it.  Smoking weed isn’t dissimilar from feeling estranged. When you’re high, food you have eaten a million times before suddenly tastes like you’re eating it for the first time, movies you have seen over and over receive new meaning, and places you visit on a regular basis – a coffee shop, a bar, a club – feel utterly alien. Not because they are, but because you become receptive to stimuli your tired old brain would normally filter out.  Being high, to me, has always reminded me of what it felt like being a child, discovering the world for the first time. There was an intensity to everyday existence that faded away with age and experience, as the new became old, the unfamiliar familiar, the extraordinary ordinary. The job of a writer – or any artist for that matter – is to recapture that intensity and freshness, and weed can help with that. 

https://hightimes.com/

Rise in Amanita Muscaria Shroom Use Worries Researchers

Step aside, psilocybin: A new shroom is in town. According to a new study by researchers at the University of California (UC) San Diego’s Herbert Wertheim School of Public Health and Human Longevity Science, the use of Amanita muscaria mushrooms has surged in the U.S. based upon Google searches. The research indicates Google searches increased by 114 percent from 2022 to 2023, according to a study published June 10 in the American Journal of Preventive Medicine. The study was written by lead author Eric Leas, as well as Nora Satybaldiyeva, Wayne Kepner, Kevin H. Yang, Raquel M. Harati, Jamie Corroon, and Matthieu Rouffet, of UC San Diego. Interest in the mushroom is growing each year. “Interest in psilocybin-containing mushrooms is increasing in the U.S., with 12.3% of U.S. adults reporting use of psilocybin-containing mushrooms in 2022, up significantly from 11.4% in 2021,” the study reads. “This makes psilocybin-containing mushrooms the most commonly used hallucinogenic substance. This growing interest in psilocybin-containing mushrooms has also sparked a new commercial market for other types of mushrooms.” Like psilocybin mushrooms, which are not closely related, Amanita muscaria mushrooms, or Fly Agaric mushrooms, also have psychotropic effects: weightlessness, visual and auditory hypersensitivity, space distortion, unawareness of time, and hallucinations, however amanitas tend to be slightly more poisonous. UC San Diego Today reports that the study shows people are taking more amanitas, perhaps without being equipped with the knowledge of doing so. Researchers noted, however, that mushrooms like psilocybin have a place in therapy, but that people should do so safely. Since amanitas are legal in most states (not you, Louisiana), they’re becoming popular and researchers think it’s due to the rise in popularity of psilocybin. “There is a lot of interest in the therapeutic potential for psilocybin and for good reason. But at the same time, a growing industry may be trying to capitalize on this interest by marketing other mushrooms. For example, some manufacturers are calling Amanita muscaria products ‘magic mushroom gummies’ and not disclosing what mushroom they contain, or not making it clear Amanita muscaria is a different mushroom than psilocybin and has essentially no clinical evidence supporting its use as a therapy,” said Eric Leas, Ph.D., M.P.H., assistant professor in the UC San Diego Herbert Wertheim School of Public Health and Human Longevity Science and senior author on the paper. The psychotropic effects are produced by compounds, mostly muscimol and ibotenic acid, its biosynthetic precursor. Researchers stressed that amanitas behave totally differently than psilocybin. Amanitas are a depressant, for instance. “There may be some pharmaceutical potential to Amanita muscaria, but muscimol does not have the same effects on the body as psilocybin, so it probably would not have the same treatment applications if it ever went through drug development. For this reason, it is misleading not to clearly distinguish between muscimol and psilocybin. If someone is consenting to a psychedelic experience, they have a right to know what substance they are taking and receive accurate information about its potential health benefits and health risks.” For the most part, what researchers are seeing is that safety protocols are mostly being ignored and the only thing you may find is a supplement-like list of ingredients. Researchers were unable to find any evidence that safety measures were taken. “We have found that many manufacturers use supplement labeling, including ‘Supplement Facts’ panels,” said Leas. “However, there is a process for bringing a supplement to market that involves presenting safety data and filing an application, and we cannot find any evidence that any of these manufacturers have gone through this process, and this makes the current products sold in this manner illegal.” Active compounds in amanitas are no toy, researchers said, and could affect certain people adversely. “In my view, if a manufacturer wanted to develop a dietary supplement from Amanita muscaria, the application probably would not be approved because of muscimol and ibotenic acids’ inherent risks,” he added. “But right now it is the ‘Wild West,’ and companies are profiting from delayed enforcement while putting consumers at risk.”  High Times has reported on the effects and history of amanitas several times before. Beginning in the December, 1976 issue of High Times, writer Tom Robbins explored amanitas and the books that inform readers about them. Then again in the December, 1979 issue of High Times, writers examined the connections between Santa Claus and a specific kind of psychedelic mushroom known as the fly agaric, aka the toadstool that conquered the universe. In fact, the mythology behind Santa could be related to a shaman in Lapland who ate Amanita muscaria.  Until more is known about amanitas, researchers urge caution for those exploring its active compounds.

https://hightimes.com/

THC Metabolite 11-OH-THC Equal or Greater in Strength as THC, Study Suggests

The primary THC metabolite that lingers in urine and blood is likely still active and as potent as THC, if not more, new data suggests. The new findings present more questions than answers. According to data from a study published June 10 in The Journal of Pharmacology and Experimental Therapeutics, the cannabis metabolite 11-hydroxy-THC (11-OH-THC) has psychoactive properties that are equal to or greater than those of THC (delta-9 THC). The study, “The intoxication equivalency of 11-hydroxy-delta-9-tetrahydrocannabinol (11-OH-THC) relative to delta-9-tetrahydrocannabinol,” demonstrates how THC metabolites remain active. THC breaks down as it’s decarboxylated and processed in the body, creating new and interesting compounds. “In this study we establish that the primary metabolite of THC—11-OH-THC—displays equal or greater activity than THC in a mouse model of cannabinoid activity when directly administered and even when accounting for route of administration, sex, pharmacokinetic, and pharmacodynamic differences,” the study reads. “These data provide critical insight into the bioactivity of THC metabolites that will inform the interpretation of future cannabinoid research and represent a model for how THC consumption and metabolism may affect cannabis use in humans.” The study was completed by Canadian researchers in Saskatchewan, including Ayat Zagzoog, Kenzie Halter, Alayna M Jones, Nicole Bannatyne, Joshua Cline, Alexis Wilcox, Anna-Maria Smolyakova, and Robert B Laprairie. Researchers observed male rats and injected them with 11-hydroxy-THC. They observed the effects of the THC metabolite versus its parent compound delta-9 THC. Researchers continued, writing “these data suggest that 11-OH-THC was 153% as active as THC in the tail-flick test of nociception, and 78% as active as THC for catalepsy. Therefore, 11-OH-THC displayed equal or greater activity than the parent compound THC, even when accounting for PK differences. Thus, the THC metabolite 11-OH-THC likely plays a critical role in the bioactivity of cannabis; understanding its activity when administered directly will aid in the interpretation of future animal and human studies.” NORML reports that 11-hydroxy-THC is one of two primary metabolites formed following cannabis consumption, along with 11-nor-9-carboxy-THC, which is not psychoactive and may linger in the bloodstream or urine for long periods of time. According to the Centers for Disease Control and Prevention (CDC), dating back to the 1980s, urine tests are primarily based on detection of 11-nor-delta-9-tetrahydrocannabinol-9-carboxylic acid (9-carboxy-THC), a metabolite of delta-9-THC, which is the primary active component of pot. Greater quantities of 11-hydroxy-THC are produced when edibles are eaten than by smoking cannabis flower, even though smoking cannabis kicks in faster than edibles. NORML reports that this is actually one the reasons why cannabis-infused edibles can become more psychoactive and create chaos for the unprepared. Evidence shows how cannabis can impact you differently, depending on the delivery route. A 2021 study published in The Permanent Journal shows how and why edibles can hit harder than smoking, due to the way 11-OH-THC is metabolized.  “The bioavailability of inhaled THC is 10% to 35%,” researchers wrote. “After THC is absorbed, it travels to the liver where most of it is eliminated or metabolized to 11-OH-THC or 11-COOH-THC. The remaining THC and its metabolites enter the circulation. The bioavailability of ingested THC is only 4% to 12%. THC is highly lipid soluble and is therefore rapidly taken up by fat tissue. The plasma half-life of THC is 1 to 3 days in occasional users and 5 to 13 days in chronic users.” Studies have shown THC metabolites like 11-OH-THC can linger in blood and urine long after the psychoactive effects of cannabis have worn off. This throws a wrench into the normal ways of testing drivers and athletes for impairment. Researchers in Australia, for instance, have been determining the window that cannabis can impair driving performance. In one case, Thomas R. Arkell, Danielle McCartney, Iain S. McGregor, who are associated with The Lambert Initiative at the University of Sydney, studied the impact of cannabis on driving ability. They determined that cannabis can impair driving ability in the hours immediately after smoking, but the impairment ends well before THC metabolites are flushed from the bloodstream, which linger for weeks or months after consuming cannabis. “Patients using THC-containing products should avoid driving and other safety-sensitive tasks (e.g. operating machinery), particularly during initiation of treatment and in the hours immediately following each dose,” the authors wrote. “Patients may test positive for THC even if they do not feel impaired, and medical cannabis use does not currently exempt patients from mobile (roadside) drug testing and associated legal sanctions.” The new findings about 11-OH-THC suggest more is to be learned about how THC metabolites affect us. More research is needed to understand the compounds more clearly.

https://hightimes.com/

Poll Results Show New Hampshire Support for Adult-Use Legalization

On June 20, the University of New Hampshire published the poll results of its numerous state topics such as Gov. Chris Sununu’s job performance, housing as the most important problem statewide, and cannabis legalization. Recently, a cannabis legalization bill (House Bill 1633) which was rejected by legislators in a 178-173 vote on June 13. To date, it was the only bill to have made such progress in New Hampshire. If passed, it would have legalized adult-use cannabis by 2026, established possession restrictions, permitted up to 15 “franchises” to sell cannabis, and set the tax rate at 15%. Despite HB-1633’s failure to pass on to Sununu’s desk, New Hampshire residents still show strong support for legalization.  “Despite broad public support, a bipartisan compromise to legalize recreational marijuana in the state was tabled by the New Hampshire House of Representatives, effectively killing the bill for this legislative session,” the report stated. “Two-thirds (65%) of Granite Staters strongly (45%) or somewhat (20%) support legalizing marijuana for recreational use, 19% are strongly (11%) or somewhat (8%) opposed, 15% are neutral on the issue, and less than 1% are unsure.” It also mentioned that support for adult-use cannabis legalization decreased from 72% in May 2023 to 65% in 2024 and attributed this change to a decrease in support by Independents and Republicans. “Large majorities of self-described socialists (97%) and progressives (95%) and most libertarians (76%), liberals (72%), and moderates (66%) support legalizing marijuana for recreational use, but only 41% of conservatives agree,” the report continued. In February 2022, a poll found that 74% of residents approved of legalization. Interestingly, only 16% of people polled said that they heard details about HB-1633, while only 45% had heard “some about it,” 28% had heard “not very much,” and 10% had heard “nothing at all.” Specifically among the 10% that heard nothing at all (approximately 1,060 participants), 37% said that they strongly support legalization, while only 24% “somewhat” support it, 14% are neutral. Additionally, also within the 10%, 23% said that they “strongly” oppose legalization, and 9% said that they “somewhat” oppose it, and 1% was unsure. The poll also inquired about why those who oppose legalization choose to do so. “Among Granite Staters opposed to the bill (N=247), only 19% oppose it because they want to legalize recreational marijuana in another way while 75% oppose the bill because they do not want to legalize recreational marijuana at all,” the results stated. “Younger opponents of the bill and self-identified Democrats are more likely to want to legalize marijuana in another way while older opponents and Republicans are more likely to not want to see marijuana legalized at all.” The House approved HB-1633 in April, and the Senate approved the bill in May before it was killed by the committee. This led to frustration on both sides, especially since in May 2023 Sununu said that he would sign a legalization bill if it contained certain restrictions. “During my years as Governor, a bill to legalize marijuana in New Hampshire has never garnered enough bipartisan support to reach my desk. I have never vetoed legislation to legalize recreational marijuana,” Sununu said at the time. “In 2017, I was proud to be the first Governor in New Hampshire history to sign legislation decriminalizing small amounts of marijuana so that no one would go to jail for simple possession. We expanded access to medical marijuana and provided a pathway to annul old convictions for marijuana possession.” More recently in May, Sununu confirmed that his statement still stands. “I laid out the eight or 10 things that I’d like to see in that bill for it to get a signature on my desk,” Sununu told WMUR in an interview. “If they meet those stipulations, I’ll sign it. If they don’t, I won’t.” Last week when the bill failed to pass, Rep. Jared Sullivan described the amended Senate version of the bill as “ugly” and “the most intrusive big-government marijuana program proposed anywhere in the country, one that ignores free market principles, will stifle innovation in an emerging industry and tie future generations of Granite Staters to an inferior model indefinitely.” Sullivan also disagreed that the bill could be reapproached next year, referencing the House stance in opposition of having cannabis be a state-run franchise model. “Does anyone in here actually believe that we will be able to reel in a newly empowered government bureaucracy after they’ve spent millions of dollars?” said Sullivan. “Does anyone honestly believe it will be easy to pull back power from an unelected agency once they have it?” Sen. Shannon Chandley spoke more positively about the bill to AP News. “This bill does address what the people of our state want,” Chandley said. “And besides being the will of the majority, it allows us to do what is really necessary, and that is to regulate.” ACLU of New Hampshire executive director Devon Chaffee called out legislators on refusing to make choices based on their constituents. “Marijuana legalization is not just a political squabble about the economic benefits,” Chaffee said. “The war on marijuana has real-life impacts.”

https://hightimes.com/

New Report Showcases Potential of Pennsylvania Adult-Use Industry Following Legalization

Responsible PA, a Pennsylvania-based advocacy group, recently partnered with FTI Consulting to determine important data about the state’s cannabis industry potential. FTI Consulting analyzed trends exhibited in other states surrounding reform and legalization and came to the conclusion that adult-use cannabis sales in Pennsylvania could reach anywhere between $1.7 billion to $2.8 billion within its first year of operation. The report was released during a digital news conference held on June 20 by Responsible PA. “There’s an enormous economic impact the state of Pennsylvania has left on the table year after year,” said Responsible PA spokesperson Brit Crampsie. FTI Consulting stated that the sales projection includes the assumption that the state may implement a 6% retail sales tax, in addition to a 15% excise tax and other applicable taxes to consider. Additionally, the projection estimates that the state would collect $420 million to $720 million in cannabis tax revenue during the same time period. A surge in legal cannabis businesses would also bring a slew of job openings, and FTI Consulting stated that legalization would lead to 26,250-44,500 new jobs. “Nearly two-thirds of the jobs supported by the adult use market would be direct cannabis jobs, with the remaining third supported indirectly or through induced spending,” the report stated. The report also added that the state would need to approve 43-100 retail licenses in order to properly serve the state as a whole. Adult-use cannabis has not yet been legalized in Pennsylvania, but there are numerous efforts trying to get legalization passed. On June 17, Rep. Aaron Kaufer and Rep. Emily Kinkead announced the introduction of their bill. Currently it doesn’t have a numbered designation, and will not receive one until later this month, but a report from WVIA said that according to Kinkead, it will be called House Bill 2500. If passed into law, the bill would “foster job creation and generate significant tax revenue for the Commonwealth, while helping eradicate the illicit market plaguing many communities.” According to Kaufer, the Pennsylvania medical cannabis program would serve as a foundation for adult-use legalization. “This bill underscores our commitment to responsible regulation of the cannabis industry while addressing the diverse needs of Pennsylvania’s communities,” said Kaufer. “By prioritizing public safety and consumer protection, this legislation will build on the successful regulatory structure of the state’s medical cannabis program, continuing stringent standards for product quality, packaging and labeling to ensure the well-being of all consumers.” Kinkead stated that adult-use legalization is long overdue. “It is well past time for the Commonwealth to legalize cannabis for recreational use, address the injustices of the failed War on Drugs, and ensure that Pennsylvanians can benefit from this industry in the same way our neighboring states have,” said Kinkead. “Our bipartisan effort to provide specific language that takes the best practices from other states is the next substantial step in finally getting this done.” Pennsylvania Gov. Josh Shapiro revealed his 2024-2025 budget proposal (approximately $48.3 billion in spending) earlier this year in February, which included a call to legalize cannabis. “I ask you to come together and send to my desk a bill that legalizes marijuana. But that bill should ensure the industry is regulated and taxed responsibly,” Shapiro stated. “We’re losing out on an industry that, once fully implemented, would bring in more than $250 million in annual revenue. And our failure to legalize and regulate this only fuels the black market and drains much-needed resources for law enforcement. It’s time to catch up.” If cannabis is accepted in Shapiro’s budget, it would legalize adult-use cannabis starting on July 1, 2024, with an estimated sales start date on January 1, 2025. His pitch includes a 20% tax on adult-use cannabis, which would net more than $250 million in annual tax revenue. He also included the need for expungement for those who have been convicted of cannabis-related crimes and stated that the Department of Agriculture would helm the adult-use cannabis program. Additionally, the legislature would need to come up with the rest of the details. However, Shapiro’s budget is due by June 30 and news reports show that cannabis legalization is likely not going to be included. Rep. Dan Frankel said that passing legalization is “probably not a realistic timeframe,” however, he did tell Spotlight PA that they “are on a path to get this done. Another bill, Senate Bill 846, was first introduced in 2023 by Sen. Dan Laughlin and Sen. Sharif Street, and would permit medical cannabis businesses to sell adult-use cannabis while also implementing rules to assist social equity applicants who want to take part in the industry. Additionally, A House Co-Sponsorhip Memoranda was published on June 17, which calls for adult-use cannabis legalization and the implementation of regulations, product packaging requirements, law enforcement funding, farmer support, and job generation. “Accordingly, we believe that now is the time for Pennsylvania to move in a similar direction and our bill establishes strong tenets for an adult-use market,” the bill text stated.

https://hightimes.com/

Brand Spotlight: Tonic

As someone who started in the medical cannabis space, I was completely freaked out when the hemp CBD craze emerged. To this day, there’s no head of the hemp world. That’s why, for many years, when someone asked for a reliable CBD topical for sore muscles or a tincture for mental calm, I recommended TONIC. I interviewed the founder, Long Island native Brittany Carbone, for an article that centered around the tours she’d hosted at her hemp farm in 2018, and the more we talked, the more I was impressed. Carbone and her husband grew and harvested their own hemp, processed the plant material themselves, and formulated their own products. Carbone was among the only independent CBD brands growing their own hemp in 2017, and she was also an early face at cannabis-related events in general, helping build a new cannabis community of people looking to get into the legal cannabis or hemp game. In addition to inviting tours out to the farm, Carbone is passionate about empowering people to make the most of their newfound right to grow cannabis at home and connecting good people, like when she helped Housing Works, New York’s first legal shop, get in touch with trusted, licensed brands when they were frantically filling shelves for launch. Now, TONIC has a THC line of vapes, gummies, and pre-rolls stocked in New York dispensaries in addition to their hemp CBD offerings, which is a damn good thing because while I am a fan of their gummies, their CBD face oil remains my skin’s favorite weed-related product. Excerpted with permission from Green Scenes by Lauren Yoshiko, published by ‎Hardie Grant Publishing, March 2024.

https://hightimes.com/

The Art of Cannabonsai

Growing up in Hawaiʻi, Davin Carvalho was always drawn to the outdoors. He and his friends would skateboard, surf, and explore Oʻahu’s west side, enjoying the warm sun, breezy tradewinds, and cool waters around Mākaha Beach. As he grew older, he sought new hobbies that would keep him outside, and eventually discovered gardening. Today, Carvalho is known for his cannabonsai trees, which possess a Zen-like aesthetic and offer an enlightened high through the flower that they provide. Carvalho’s journey as a gardener started early, when he began growing kalo as a kid. Kalo, or taro in Hawaiian, is a root vegetable that is inextricably linked to Hawaiian culture. According to mythology, the kalo plant represents the original ancestor and elder brother of all Hawaiians. For Carvalho, who is indigenous, growing kalo bound him to his familial roots. With around 100 plants in his garden, he could happily spend over an hour watering, fertilizing, and pruning on a daily basis. For reasons unknown, in late 2020 Carvalho began to experience debilitating panic attacks. After two months of agony and countless emergency room visits, he discovered that gardening was a tool he could use to manage his anxiety. A friend sent him some traditional bonsai videos, which were relaxing and educational at the same time. Before long, Carvalho bought a couple ficus and juniper trees and began to seriously study Chinese and Japanese bonsai as a form of therapy. During that same period, Carvalho decided to apply for official documentation with Hawaiʻi’s Medical Cannabis Registry, allowing him to grow marijuana for personal use. After realizing that traditional bonsai requires decades of devotion, he decided to adapt bonsai techniques to pakalolo which allowed him to grow beautiful, medicinal plants in a shorter period of time. Through research on the topic, Carvalho learned that the bonsai “effect” comes as a result of training a plant. In the world of cannabis, training is nothing new. It’s common practice for growers to train plants for a higher yield and denser buds. By gently manipulating branches or tilting the pot the plant is in, Carvalho can create the bonsai effect as a result. “My objective when I’m training my plants is to make it look like a replica of a full-size tree,” Carvalho said. “I try to think, ‘How many branches do I want? What do I want the canopy shape to look like? Do I want it to be a taller tree, a shorter tree? A bushier tree or a lankier tree?’ I keep all that in mind.” Although he does not necessarily speak to his plants, Carvalho spends a lot of time in close proximity to them. Doing so promotes the exchange of oxygen and carbon dioxide, with both parties benefiting in the process. By providing for his plants and helping them thrive, he hopes that they will return the favor. “Gardening itself is a language. I might not speak verbally to them, but there is nonverbal communication with the plants in my garden and myself,” Carvalho said. “It’s a constant sending and receiving of messages in order for us to achieve understanding and reach a common goal, which is for the plants to flower and produce beautiful buds.” In his most recent run, Carvalho incorporated rose quartz and amethyst, a crystal that is said to promote calmness and relaxation. When preparing for a new harvest, he is intentional about the overall aesthetics the cannabonsai will have, from top to bottom of the plant. “I’ve done a little bit of research, but I’m definitely no expert. I wanted to make sure that if I was gonna use crystals, I wanted to know which combinations of crystals can go together,” Carvalho said. When it comes to cultivating a successful cannabonsai tree, genetics play a huge role. To capture the bonsai aesthetic, Carvalho grows indica-leaning strains as they are shorter, bushier, and have tighter internodal spacing than sativa-leaning strains. After three years of research and experimentation, Carvalho believes that each cannabonsai run has improved from the previous one. As much as gardening is an outlet to relax, it also provides a challenge that keeps him wanting more. No matter how much knowledge and experience he gains while growing, there are inevitably hurdles that humble and teach him along the way. “If it was as easy as putting a seed in the ground and watering it, it wouldn’t be as fulfilling to me,” Carvalho said. “Anybody could do that. But to really have the commitment, dedication, passion, and drive, that’s what really gets me. I like something that’s not so easy to obtain but is something that if I work hard at it, I can either get it, or get something close to it and have something that I am happy with.” This article was originally published in the June 2024 issue of High Times Magazine.

https://hightimes.com/

Popular Ways to Consume Cannabis

There are numerous methods to consume cannabis, but there is no single “best” method. Each provides a distinct experience and benefits, catering to a variety of interests and demands. Smoking is perhaps the most traditional and extensively used practice, and it produces immediate effects since it is swiftly taken into the bloodstream via the lungs. Vaping, on the other hand, has gained popularity as a potential healthier alternative. If you don’t like inhaling, edibles could be a good alternative. These cannabis-infused foods and drinks are discreet and deliver a longer-lasting experience, however they take a little longer to take effect. Finally, there are tinctures and oils, which are extremely flexible. They can be taken sublingually or mixed into recipes. Each approach provides varied levels of dosage and onset time, so when deciding how to take cannabis, consider what works best for your needs and lifestyle. Let us look at each method in detail. Smoking cannabis is a very traditional and still a common way to consume it. This involves lighting the dried buds and inhaling the smoke. It works quickly, so it’s popular for fast relief. Pipes are small and portable, making them a convenient option for on-the-go use. Typically made from materials such as glass, metal, or wood, pipes available at KING’s Pipe Online Headshop require minimal preparation and are easy to use. Simply pack the bowl with ground cannabis, ignite, and inhale through the mouthpiece. This method provides a straightforward, no-fuss way to enjoy cannabis. Bongs, on the other hand, add an element of water filtration to the smoking process. These larger devices, often crafted from glass or acrylic, available at the American 420 Smoke Shop, allow the smoke to pass through water before reaching your lungs, which can result in a smoother and cooler inhalation. This makes bongs a popular choice for those who find regular smoking a bit harsh on the throat and lungs. The filtration process may also help to remove some impurities from the smoke, potentially offering a slightly cleaner experience. Chillums are for those seeking a more traditional and culturally rich method. Originating from India, these straight, conical pipes are usually made from clay, glass, or stone. Using chillum involves placing ground cannabis in the narrow end, lighting up, and inhaling through the wider end. This method requires a bit more technique compared to pipes and bongs, but it offers a unique, ritualistic experience that many users find deeply satisfying, complemented by the precision of a sharpstone weed grinder. For Gen Z, Vaping is so far the most popular alternative to smoking. By heating cannabis flowers or concentrates at lower temperatures, it creates a smooth vapor ready to be inhaled. Many people, not just Gen Z, like vaping because it’s cleaner and more refined than traditional smoking. Dabbing is a potent method that involves vaporizing high-THC concentrates known as dabs. This method typically requires a dab rig, which consists of a water pipe fitted with a nail or banger made from materials like quartz, ceramic, or titanium. A blowtorch is used to heat the concentrate before inhaling the vapor through the dab rig. Dabbing offers intense effects due to the high concentration of THC, making it a method favored by experienced users who are looking for a more powerful experience compared to traditional smoking. Because of its potency, dabbing is often approached with caution by newcomers, and users are advised to start with small amounts to gauge their tolerance. Dry herb vaporizers are an advanced and health-conscious way to consume cannabis. They heat the flower to a temperature that vaporizes active compounds without burning the plant material, resulting in smooth and flavorful vapor. This method lets you enjoy cannabis’s therapeutic benefits with minimal respiratory risk. These vaporizers are versatile, user-friendly, and readily available at online vape stores like Mind Vapes Online Shop. Many models feature precise temperature control, enabling you to target specific compounds and flavors. Dry herb vaporizer maximizes the plant’s natural profile while reducing exposure to harmful byproducts of smoking. With long-lasting vape battery life, they offer extended sessions without the need for frequent recharging. Their discreet and portable design makes them ideal for unobtrusive use. Edibles are food products infused with cannabis extracts, providing a discreet and smoke-free way to consume cannabis. They come in a variety of forms, such as gummies, chocolates, baked goods, and snacks. Edibles offer a longer-lasting and often more intense experience compared to smoking or vaping, but they also take longer to take effect, typically between 30 minutes to 2 hours. Dosage control is crucial to prevent overconsumption, as the effects can be strong and long-lasting. Cannabidiol oils are concentrated extracts that can be taken as pills, added to food and drinks, or taken sublingually. These oils are designed to meet different medicinal requirements and preferences and often contain either CBD, THC, or a combination of both. Oils are popular because of their accurate dosage and ease of application. They offer a controlled and consistent experience, making them the preferable option for individuals using cannabis for medical purposes. People now have a familiar method to enjoy cannabis thanks to the rising popularity of drinks infused with cannabis. Teas, coffees, sodas, and alcohol substitutes are available options. Similar to edibles, the effects wear off in 30 to 2 hours. These drinks offer a controlled and enjoyable experience, usually with lower doses for moderate and social use. Tinctures are liquid extracts containing cannabis. They are normally created by immersing cannabis flowers in high-proof alcohol, which extracts the active ingredients. The resulting combination is then filtered and bottled, frequently with flavorings added to enhance taste. Tinctures are typically delivered sublingually, which means a few drops are inserted beneath the tongue and rapidly absorbed into the bloodstream. This approach enables rapid onset of effects as well as exact dosage control. A convenient and enjoyable alternative to smoking or vaping for consuming cannabis is through capsules. They are made of powder or oil that has already been pre-infused with a specific amount of cannabis. This ensures consistent effects every time by making it simple to monitor and control intake. Capsules are ingested orally and pass through the digestive system, which means the onset of effects can be slower compared to tinctures, but the duration of the effects is often longer. Sprays provide another convenient option for cannabis consumption. They can be easily and discretely dosed because they are usually sold in compact bottles with a pump or spray nozzle. Cannabis sprays frequently include liquid cannabinoid extracts, just like tinctures do. They can be sprayed into the mouth directly, or on food and drink to be consumed. Many people find this approach to be a versatile option because it combines ease of usage with a speedy onset. Topical applications entail putting cannabis-infused goods directly on the skin. These treatments, including as creams, lotions, and balms, are popular for providing regional relief while avoiding psychoactive consequences. They are perfect for providing targeted pain and inflammation relief.

https://hightimes.com/

You Know What I Learned After a T-Break? That I Really Love Smoking Weed

Much ink has been spilled over the hallowed tolerance break, affectionately known to us stoners as the slightly threatening, slightly alluring “T-Break.” When you should take them, what they are, why you should take them, and a lot of other thoughtful discussions, that I have participated in, too, all with the goal of being a more thoughtful cannabis consumer. But something in the T-break assumption has always struck me as a little off, a little self-stigmatizing. The baseline assumption is that there’s an inherent threshold of negative amounts of cannabis use for everyone, and I want to try and unpack it here with like-minded readers. Let me go on record as saying that T-Breaks are incredibly beneficial. While I can only moderately speak to the science behind why, as I’m not a doctor, I also think it’s never a bad idea to evaluate habitual behavior. See if you’re actually paying attention to things, whether or not they are helping or hurting.  There was a time a couple of years ago, before I got pregnant and had a baby when I was wondering this for myself, whether or not my cannabis consumption was a problem. I smoke a lot of weed. Wake-and-bake, throughout the day puffing and bongs, evening edibles and more bongs and joints. On weekends, I typically also eat edibles during the day. For context, I’m a mother to a one-year-old, a wife, and I help run creative strategy for a media company, in addition to running my cannabis newsletter https://cannabitch.substack.com/. I don’t drink very much, except when tasting wine or cocktails for work, and I’ve got a busy, heady life. I think cannabis helps me—I enjoy how I feel in body and mind after using it, and because I have ADHD, for which I do not take pharmaceutical medication, I also believe it helps to settle my mind and keep me focused. But I dunno. Everyone else says that smoking lots of weed is very bad for you! Even pro-stoner movies, like Half Baked, revolve around the premise of, “Holy shit, these people light up a lot. Let’s make it a punchline.” At the end of that movie, which is presented as a happy, pro-head conclusion, Thurgood (Dave Chappelle’s character) reveals he’s still smoking weed, which was his struggle versus his anti-weed girlfriend, Mary Jane, all along. Hurrah! But the catch is that it’s still a secret, and the movie fades to black. How is that a win if you still have to hide it!? And that’s just the media that’s created specifically for us. The rest of it is even more judgemental. So it’s no surprise that anti-weed stigma seeps into even the most THC-laden brains, like mine, even though I should know better. That said, I am a journalist and writer by trade and nature, so I’m down for a little healthy skepticism. I’ve embarked on various T-Breaks of various lengths, some as short as a day or two, others as long as a year, back around a decade ago, and, more recently, one that was about nine months long, give or take (I was pregnant). Before I got pregnant, I was consuming more than I ever had in my life, and that’s where the wondering around my use started to ratchet up in my brain. For years, I had been at the point where I knew I couldn’t go a day without using cannabis, couldn’t buck the urge. That bothered me in theory more than in practice: my multiple-times-a-day consumption wasn’t affecting my daily life negatively, per se, but I didn’t like nor trust the compulsion. Life took care of that for me in short order: During this period, I became pregnant and promptly stopped consuming anything with THC. Then, I had my baby, who was happy and healthy and who remains so.  Now, 13 months later, I’m back to consuming throughout the day at levels that would frankly scare most people, especially mothers and folks who have traditional ideas about how mothers should behave and what substances they should consume and when. I work full-time, and I’m firing on all cylinders. I check in with my health practitioners, including my therapist, who is 420-friendly and believes my use helps me manage my ADHD. I spend a lot of time at home with my son and my family. I’m happy, functional, healthy, and, truthfully, currently living my best life. So, what did I learn after all this thinking and breaking, only to end up more-or-less in the same spot? I’m sure there are many reading this who would be like, “Jackie, you’re addicted to weed,” and that conclusion is supposed to be a bad thing. That I can’t or won’t stop, despite society loudly or quietly hinting I should, and designations swirling around medicine and media like “Cannabis Use Disorder,” which I certainly qualify for, saying my use is problematic. But even if these designations are accurate, if that’s the case, who is it hurting at this present moment? Certainly not me, nor anyone in my family. Not my employers, not my friends. So I’m just not sure it matters, and I think the only person I’ve needed to answer to this whole time is me, and clearly, I lost sight of that.  So I’m just going to say it once and for all: I consume a ton of weed, and I absolutely love it. Not much more I need to say beyond that.

https://hightimes.com/

NY Advocates Rally After Governor Ignores Recommendations from State’s Own Experts

Advocates held a rally on Tuesday, following last week’s revelations by The City’s Rosalind Adams showing the plan to finance New York’s cannabis industry moved forward despite the major concerns of numerous people involved in the process of implementing the state’s recreational cannabis program. The Juneteenth Eve rally included elected officials, social justice advocates, and people impacted personally by New York’s longtime war on cannabis. They hoped to protect the progressive aspects of New York’s legalization law, prevent corporate control and increase the weight of community voices moving forward. Chief among those advocates’ concerns across the 500 emails obtained by The City got access to was the fact that the deal sucked. The things that immediately raised eyebrows included steep costs and unreasonable repayment timelines. Most importantly these concerns were raised with the Governor Kathy Hochul as her office pushed to make her previous promises on funding the cannabis program a reality.  “The social equity component of the MRTA is absolutely essential for our communities in Brooklyn and Queens,” said Senator Julia Salazar. “MRTA implementation is a chance to address the harm that too many New Yorkers have experienced due to many years of criminalization. But the encroachment of big cannabis corporations in New York’s market poses a threat to the MRTA’s success, especially for small, legal cannabis businesses. For the good intent of the MRTA to become reality for more communities of color and justice-impacted New Yorkers, we need Governor Hochul to allow the Cannabis Control Board to function as an independent body, and for the Office of Cannabis Management to be empowered to continue to implement the MRTA equitably.” Salazar hit the nail on the heart in terms of who should be taking the lead. The concerns from New York’s Office of Cannabis Management about the funding deal were ignored. Following the struggle for New York to provide true access statewide, the OCM was thrown under the bus for the state’s failure despite raising numerous red flags they found and raised about the Chicago Atlantic Group deal. The City noted an OCM financial analyst used all caps to note how BAD it was.  The Drug Policy Alliance calls New York City home and has been at the forefront of the work to get New York legal over the years. Executive Director Kassandra Frederique offered a scathing critique as news first got out about Hochuls’s administration moving ahead with a predatory lender that exploited Black and Brown cannabis licencees while keeping lawmakers in the dark.  Frederique called the Hochul administration’s mishandling of the legal marijuana rollout deeply concerning, and strikingly echoed the Governor’s congestion pricing reversal.  “In both instances, she bypassed the Legislature’s will and rejected agency expertise to enact sweeping changes without a concrete plan,” Frederique said, “It’s now clear that her administration knew of DASNY’s failures to build retail space and ignored repeated warnings from the Office of Cannabis Management about predatory loans harming mostly Black and Brown licensees. Instead of addressing these issues, the Hochul administration agreed to unfavorable loan terms with a disreputable creditor and then scapegoated the former OCM leader for the rollout’s failures. Frederique went on to note how devastating this was to the communities of color most decimated by disproportional enforcement of the state’s cannabis laws in their neighborhoods.  “What Governor Hochul calls social equity has only made cannabis licensees more vulnerable to exploitation,” Frederique said, “Our communities deserve better—real equity, real opportunities, and an administration that follows the law’s intent. The Governor must present a clear plan for delivering the next phase of our justice-centered cannabis framework in accordance with the law.” Shaleen Title has spent the last two decades pushing for an equitable cannabis industry. She is founder and director of the drug policy think tank Parabola Center, which creates model policies to protect people rather than corporate profits. She currently serves as Distinguished Cannabis Policy Practitioner in Residence at The Ohio State University Moritz College of Law’s Drug Enforcement and Policy Center and as vice-chair of the Cannabis Regulators of Color Coalition. It’s tough to find a voice that carries more weight on the regulatory side when it comes to discussing Social Equity in cannabis.  We asked Title her thoughts on what was happening in New York. She said DPA offered a great statement on the subject already but offered some further reading. “The governor’s narrative that the Office of Cannabis Management was “inexperienced” deserves further examination,” Title said, “The new evidence shows that the governor’s office ignored OCM’s warnings and moved ahead with a failed initiative and then used the OCM and its leadership as a scapegoat.” Title closed pointing to the positive aspects of what is happening in New York despite the hiccups.  “Any fair evaluation of New York’s rollout comparing its metrics against its own goals, and metrics in other states, demonstrates that New York leads the nation in terms of racial equity and cannabis — not surprising, given that its staff has been led by some of the country’s top experts on cannabis and equity, data, civil rights law, and antitrust law,” Title said,  Ahead of the rally outside of Hochul’s office, DPA noted other positives from New York’s rollout being overshadowed in the controversy of the moment. Those include things like 95% of New York’s cannabis retail market is small businesses. But more importantly, New York has nearly tripled the number of Black-owned retail dispensaries nationwide in just 15 months. “The Governor can change the players, but for NY activists who know that this is a marathon for equity and not a sprint, the game doesn’t change. We will continue to hold her accountable to the letter of the most equitable cannabis law in the country. This means that fifty percent of the market must be comprised of social equity outcomes including those from communities disproportionately impacted by cannabis prohibition. We will not stop advocating for the state budget and support that it will take for NY to get there, despite the machine, including MSOs, that we are up against,” said Annette Fernandez, Managing Partner, High Exposure Agency; Founder, La Casa Lola; and Provisional Retail License Applicant.

https://hightimes.com/

Justice Advocates Call For More Relief After Maryland Governor Pardons Thousands

Restorative justice advocates in Maryland are calling on Democratic Governor Wes Moore to take additional steps to provide relief to those with marijuana-related convictions, only days after the governor announced he was pardoning thousands. Moore signed an executive order on Monday that issued a mass pardon for approximately 175,000 weed-related convictions, a move that affected the records of about 100,000 individuals. “Maryland made history when we legalized cannabis by referendum. But we cannot celebrate the benefits of legalization while forgetting the consequences of criminalization. No Marylander should face barriers to housing, employment, or education based on convictions for conduct that is no longer illegal,” Moore said when he announced the pardons on Monday. “Today, we take a big step forward toward ensuring equal justice for all. But this won’t be our last effort. We must continue to move in partnership to build a state and society that is more equitable, more just, and leaves no one behind.” With the governor’s action this week, Maryland joins a growing number of states that have issued thousands of pardons to absolve convictions for cannabis-related offenses, particularly as laws prohibiting marijuana are relaxed across the country. A similar move was made at the federal level, with President Joseph Biden becoming the first president to issue a mass pardon for marijuana crimes in October 2022. The president expanded his order in December 2023 with a pardon that covered thousands more federal marijuana convictions. According to Paul Armentano, deputy director of the National Organization for the Reform of Marijuana Laws (NORML), approximately 2 million people have had a cannabis-related conviction pardoned or expunged in recent years, The Washington Post reported on Wednesday. Supporters of the mass pardons note that a criminal conviction, even for a minor offense, can have long-lasting repercussions. In an interview with NPR, Moore acknowledged the difficulties faced by those with a criminal record while noting the scope of his executive order. “The barriers to everything from employment to education to the ability to buy a home and to be able to start gaining wealth for your family, all of these things are being blocked,” Moore told NPR. “By doing what is the largest state misdemeanor cannabis pardon in the history of this country, essentially what it’s doing is, we want to make second chances actually mean something.” Some justice advocates, however, say the pardons announced this week do not go far enough to ease the harm of a criminal conviction and are calling for records to be expunged instead. In Maryland, a pardoned conviction still appears on an individual’s criminal record with a notation that the offense has been forgiven. Colleen Chien, a professor at the University of California, Berkeley School of Law, said that research shows that any criminal record, even for only an arrest, can make employers less likely to contact a job candidate for an interview. “A record, whether or not it’s been pardoned, whether or not it’s been convicted, is often enough,” said Chien. “And so if the governor wants to sort of ensure that this is policy, that there is as much force behind it as possible, he would probably work with the legislature to also try to turn it from a pardon to some sort of shielding, a sealing, or an expungement.” Cynthia W. Roseberry, director of policy and government affairs focused on justice issues for the American Civil Liberties Union, said the pardons for minor cannabis convictions in Maryland and some other states are a “good first step, but it is a small step” to address what she characterized as systemic racial inequities in the nation’s criminal justice system. “This really is a signal that elected officials are beginning to listen to the people,” Roseberry told The Washington Post. “The people want folks to do more, and I think elected officials have to be bold enough to follow the people in that way.” The Clean Slate Initiative is a campaign supporting legislation for the automated clearing of criminal records known as clean slate laws. Leaders of the initiative estimate that 300,000 people in Maryland have convictions for marijuana-related offenses and other crimes that are eligible for expungement that the state has not yet cleared. “Pardons and other efforts to reduce the consequences of having a record are important,” Sheena Meade, CEO of the Clean Slate Initiative, told NPR in an email. “However, automatic record clearance for people who meet the requirements is the best way to ensure that a past mistake does not prevent people from having meaningful access to employment, housing, education, and other opportunities.”

https://hightimes.com/

Feds Indict 24 in Mexico Cartel and China Drug Operation Alliance

The Justice Department and the U.S. Drug Enforcement Administration (DEA) announced on June 18 a 10-count superseding indictment, charging Los Angeles-based individuals linked to Mexico’s Sinaloa drug cartel with conspiring with money-laundering groups linked to a Chinese underground banking network in order to launder drug trafficking proceeds. Cartel members linked to Mexico used a Chinese underground banking system in order to launder money made from selling meth and cocaine. The Sinaloa Cartel is one of the largest-known crime syndicates in the world. It was run, famously, by Joaquín “El Chapo” Guzmán, who is currently serving a lifetime sentence at a maximum security prison in Colorado. Investigators also say the Sinaloa cartel is responsible for a glut of fentanyl in the country for the past eight years. Called “Operation Fortune Runner,” federal agents issued the indictment on April 4 and it was unsealed on Monday, charging a total of 24 defendants with one count of conspiracy to aid and abet the distribution of cocaine and methamphetamine, one count of conspiracy to launder monetary instruments, and one count of conspiracy to operate an unlicensed money transmitting business. Throughout the course of the conspiracy, over $50 million in drug proceeds flowed between the Sinaloa Cartel associates and Chinese underground money exchanges. Authorities in both Mexico and China alerted U.S. law enforcement that they had caught suspects attempting to flee the U.S. after being charged last year. To transfer money to the United States, a China-based investor contacts an individual who has U.S. dollars available to sell. Then the seller of U.S. dollars provides identifying information for a bank account in China with instructions for the investor to deposit Chinese currency into that account. Once the owner of the account sees the deposit, an equivalent amount of U.S. dollars is released to the buyer in the United States. Edgar Joel Martinez-Reyes, 45, of East Los Angeles, who is being named the lead defendant, and others allegedly used a variety of methods to hide their trail of money, “structuring” assets to avoid federal financial reporting requirements, and the purchase of cryptocurrency.  Federal authorities also found a cache of cocaine, shrooms, ecstasy, meth, and ketamine. “Relentless greed, the pursuit of money, is what drives the Mexican drug cartels that are responsible for the worst drug crisis in American history,” said DEA Administrator Anne Milgram. “This DEA investigation uncovered a partnership between Sinaloa Cartel associates and a Chinese criminal syndicate operating in Los Angeles and China to launder drug money. Laundering drug money gives the Sinaloa Cartel the means to produce and import their deadly poison into the United States. DEA’s top operational priority is to save American lives by defeating the cartels and those that support their operations. This investigation is the latest example, and there is more to come.” Twenty of the individuals named in the indictment are expected to be arraigned in the U.S. District Court in downtown Los Angeles within weeks, including one who was arraigned on Monday. “Dangerous drugs like fentanyl and methamphetamine are destroying people’s lives but drug traffickers only care about their profits,” said U.S. Attorney Martin Estrada for the Central District of California. “To protect our community, therefore, it is essential that we go after the sophisticated, international criminal syndicates that launder the drug money. As this indictment and our international actions show, we will be dogged in our pursuit of all those who facilitate destruction in our country and make sure they are held accountable for their actions.”  The investigation involved IRS authorities as well that helped track down the paper trail. “Drug traffickers generate immense amounts of cash through their illicit operations. This case is a prime example of Chinese money launderers working hand in hand with drug traffickers to try to legitimize profits generated by drug activities,” said Chief Guy Ficco of IRS Criminal Investigation. “We have made it a priority to identify, disrupt, and dismantle any money launderers working with drug cartels and we are committed to our partnerships with federal, state, and local law enforcement agencies to combat drug cartels and those who assist them in laundering drug proceeds.” As part of this investigation, law enforcement reported they had seized approximately $5 million in drug  proceeds,with  302 pounds of cocaine, 92 pounds of methamphetamine, 3,000 Ecstasy pills, 44 pounds of psilocybin (magic mushrooms), numerous ounces of ketamine, three semi-automatic rifles with high-capacity magazines, and eight semi-automatic handguns. The Department of Justice announced similar indictments last January.  Dozens of individuals allegedly linked to the most powerful cartel in Mexico were arrested and charged by federal agents in California and elsewhere in the western United States, the Department of Justice announced in January.  The DOJ said that 14 “indictments were unsealed, charging 47 alleged members of an Imperial Valley, California-based, Sinaloa Cartel-linked fentanyl-and-methamphetamine distribution network with drug trafficking, firearms, and money laundering offenses.”

https://hightimes.com/

Psilocybin Treatment Centers Bill Vetoed by Arizona Governor

Arizona Gov. Katie Hobbs vetoed a bill on June 18 that would have permitted the use of psilocybin in designated treatment centers. If House Bill 1570 became law, it would have granted $5 million in annual funding to go toward psilocybin therapy. The Department of Human Services would have been in charge of the program and developing a regulated approach to licensing therapy centers as well as facilitators who would be trained to assist patients through the experience. Additionally, the Arizona Psilocybin Advisory Board would have also been created, consisting of a variety of members such as the governor, attorney general’s office officials, military veterans and first responders, physicians, and researchers. It would be the responsibility of the board to make recommendations for the law, conduct studies, and ultimately develop a program with which to train staff to work at therapy centers. According to her veto statement, Hobbs explained her stance on the bill. “The state’s psilocybin research advisory board established last year recently issued its annual report, with a clear message: although psilocybin may be a promising treatment in the future, we do not yet have the evidence needed to support widespread clinical expansion,” Hobbs said. “Arizonans with depression and PTSD deserve access to treatments that may be seen as outside the mainstream, but they should not be the subject of experiments for unproven therapies with a lack of appropriate guardrails.” In her letter, Hobbs continued by adding that the cost of $400,000 per year was not included in the FY25 budget. “Last year’s budget included $5 million for psilocybin research which will be allowed to continue with this year’s budget,” she concluded. “This will allow research to take place with a goal to ensure that those who seek psilocybin treatment are doing so confidently and safely under proper supervision of qualified professionals with documented and verified research to support the treatment.” Cameron Arcand, a reporter for local Arizona news outlet The Center Square, published a screenshot of a text sent to him by the bill’s sponsor, T.J. Shope, on social media. “Well, it’s a disappointing result after months of hard work and the overwhelming bipartisan support this received in both houses of the Legislature this year,” Shope stated. “If we were still in session, I’d be pushing to override her veto but I’ll have to settle for trying again next year. I won’t stop fighting for our veterans and first responders to get the mental health care they deserve in these clinical settings. Sadly, Arizonans will now have to continue leaving their own state and country to receive this type of treatment. It’s truly a sad day for those who have put everything on the line for us.” Arizona now joins California in having bipartisan support on a psilocybin treatment centers bill being vetoed by its governor. Similarly in October 2023, California Gov. Gavin Newsom vetoed Senate Bill 58, which would have decriminalized possession and use of psilocybin, psilocyn, DMT, and mescaline for adults over 21. While Newsom confirmed that he supports new methods of treatment to tackle mental health conditions, the bill was not yet ready to be passed, in his opinion. “California should immediately begin work to set up regulated treatment guidelines—replete with dosing information, therapeutic guidelines, rules to prevent against exploration during guided treatments, and medical clearance of no underlying psychoses,” Newsom explained in a statement at the time. “Unfortunately, this bill would decriminalize possession prior to these guidelines going into place, and I cannot sign this.” SB-58 sponsor, Sen. Scott Weiner, expressed his disappointment for the setback, although he plans to continue to fight for alternative drug treatments for veterans and first responders. “This veto is a huge missed opportunity for California to follow the science and lead,” Weiner stated. “This is not the end of our fight, however, and given the Governor’s commitment to work with the Legislature on legislation with a therapeutic focus—and openness to future decriminalization legislation—I look forward to introducing therapeutic-focused legislation next year.” Weiner introduced new legislation under Senate Bill 1012 in February, but currently the last action taken was in May so far. While Oregon was the first state to legalize licensed psilocybin treatment centers back in November 2020 (although the first license wasn’t approved until May 2023), the program overall appears to be struggling. Between June 2023-June 2024, an estimated 3,500 people had participated in a legal psilocybin therapy session, which is projected to increase to 7,000 people by the end of 2024. However, one treatment center owner, Tori Armbrust of Satori Farms PDX, said that treatment centers may begin to close due to lack of consistent customers. Starting in 2025, Oregon will permit out-of-state business owners to obtain licenses to operate treatment centers, which will create more competition for local business owners. Another Oregon-based psilocybin treatment center owner, Matthew Wissler, added that most patients come to Oregon from out-of-state or even out of the country to try out the treatment.

https://hightimes.com/

Vlasic Classic Charity Golf Tournament Raises Funds for Last Prisoner Project

The second annual Vlasic Classic Charity Golf mixer was recently held in Missouri by the brand of the same name, Vlasic Labs. The Vlasic Classic featured an 18-hole golf tournament in which 27 teams participated. More than 100 participants representing various advocates and legislators both from Missouri and throughout the country were drawn to the tournament at the Old Kinderhook Golf Club in the Lake of the Ozarks. The event raised $43,000, which will be granted to the Last Prisoner Project to assist people who have been imprisoned for cannabis-related crimes. This includes “supporting legal efforts, reentry programs, and advocacy work aimed at freeing cannabis prisoners and helping them reintegrate into society,” Vlasic Labs wrote in a press release.  “This event brings together the things we love most and allows us to give back to the community in a significant way. The support we received from the cannabis industry and the funds raised for the Last Prisoner Project demonstrate the positive impact we can achieve together,” said Vlasic Labs co-founder, Rick Vlasic. Vlasic Labs offers hemp-based wellness products through tinctures, topicals, and gummies, with a focus on CBD, CBG, and CBN. Additionally, the brand developed a specific line of products dedicated to pets as well. It prioritizes product experiences both for everyday consumers, as well as those who do more physically demanding work and also athletes. Immediately after the conclusion of the Missouri-based golf tournament, Vlasic Classic announced that it will be hosting another event at St. John’s Resort in Michigan between Aug. 16-18. “As Vlasic Labs prepares for the Michigan Vlasic Classic, the company is committed to continuing its tradition of philanthropy and community support,” the brand wrote. “The upcoming event promises to build on the momentum and success of the Missouri outing, furthering the impact of the Last Prisoner Project and celebrating the shared values of the Vlasic family and their partners.” Historically, the Vlasic family often took part in philanthropic endeavors. Vlasic Labs wrote on its website that before World War II, Vlasic ancestor Joseph Vlasic took part in streamlining milk delivery in the Midwest. Later with his son Robert, they developed a pickle brand that eventually became one of the most famous pickle brands in the world: Vlasic Family Pickle. Through that success, Robert Vlasic donated his accrued wealth to the Henry Ford Health System, the Michigan Humane Society, and the University of Michigan. Vlasic Labs launched its brand in 2019, co-founded by Rick Vlasic and his son, Willy, to continue on the legacy of honest family branding. “The Vlasic Family founded Vlasic Labs on the same principles and values that brought their pickles into the refrigerators of 90 million Americans: quality, consistency, and value,” the brand website stated. “Our journey from dairy to pickles, and now to hemp wellness, is driven by a mission to innovate for the betterment of society,” Rick Vlasic said in March. Rick is proud to have been taught by both his grandfather (Joseph) and father (Robert), and he forged his own path in the 1980s when he helped the “Big 3” auto companies enter the digital age by developing digital e-learning courses focused on healthcare and safety. Cannabis and golf are an excellent match. Consuming cannabis on the green is easy, and the high can last as long as the game (as long as you’ve confirmed that it’s permitted at your course of choice). Back in 2018, Golf Digest studied three golfers of three different skill levels (semi-pro, amateur, and casual) and how their performance changed after getting high with various doses (6 mg, 18 mg, 34 mg, and 50 mg). “Like everything else in life, moderation is key. A little bit of marijuana—in this case, around 18 milligrams—can help to relax muscles and calm nerves, aiding distance and overall tee-to-green performance,” Golf Digest wrote. “Consume in excess of that, however, and focus, energy, hand-eye coordination, and munchies become major impediments. In the most general terms, marijuana use on the golf course reflected our experience with alcohol: A little goes a long way, but a little too much will have you playing from the wrong fairway for the rest of the afternoon.” While that study was conducted over six years ago, plenty more studies have unveiled the benefits of cannabis when applied to other sports or forms of exercise. Some athletes have found results in using cannabis for recovery, according to a 2023 study. Another study from last year found evidence that cannabis could help some athletes prevent brain damage. The mainstream reputation of cannabis today has even led major sports organizations like the NCAA, NBA, and more, to loosen restrictions on cannabis consumption. Over time, many athletes came out publicly defending their right to consume cannabis and help treat their various sports-related conditions and injuries.

https://hightimes.com/

Poison Control Center Calls Increased Following Psilocybin Decriminalization

Recently, researchers Christopher P. Holstege and Rita Farah unveiled the results of their study on the increase in poison center calls for mushroom consumption. In “Psilocybin Exposures Reported to U.S. Poison Centers: National Trends Over a Decade,” the researchers explored the rising trend of accidental exposure to psilocybin between January 1, 2024-December 31, 2022. Holstege is a Professor of Emergency Medicine and Pediatrics and Farah is a Researcher of Epidemiology, both of which work at the University of Virginia. Over a 10-year period, there were 4,055 exposure incidents recorded by the National Poison Data System, and 2,667 (65.8%) of those incidents involved adolescents or young adults between 13-25. From this number of people, 1,176 (75.3%) were adolescents, and 797 (72.1%) were young adults. One of researchers’ noteworthy observations was that cases didn’t rise between 2013-2018, but increased after 2019, and tripled in 2022. Holstege and Farah co-wrote an analysis of their research, which was originally published in The Conversation. Researchers noted that in May 2019, Denver, Colorado became the first city to decriminalize psilocybin, which was followed shortly after by Oakland, California, in June 2019. This trend continued with various other cities across the U.S., with Santa Cruz, California, in January 2020, Washington D.C. in November 2020, Sommerville, Massachusetts in January 2021, Seattle, Washington in October 2021, and Detroit, Michigan in November 2021. Additionally, Oregon was the first state to decriminalize psilocybin and introduce a legal therapy treatment program in November 2020. This was followed by the state of Colorado in November 2022. Farah is an epidemiologist, and both of them worked together to identify potential harms. “Part of our job is to track public health risks related to poisons and to create efforts to prevent them,” the researchers wrote. “We are both concerned about the increase in calls to poison control centers related to psilocybin.” However, the information collected by the National Poison Data System covers calls from across the country, making it impossible to know where exactly the poison calls came from. The data shows that a majority of the reported calls between both adolescents and young adults resulted in the need for medical attention at a hospital or treatment facility. A majority of these cases included people who were experiencing “hallucinations, delusions, agitation, rapid heart rate, and confusion.” Holstege and Farah expressed their overall concern for youth based on their observations. “Our findings correspond with a review of more than 30 studies that demonstrates a similar rise in acute cannabis poisoning among children and adolescents beginning after marijuana was legalized in 1996,” the researchers concluded. “We find this particularly alarming, since the states that legalized and cities that decriminalized psilocybin don’t allow anyone under 21 to use it or buy it. This suggests young people are getting it illegally.” A study recently published in the Drug and Alcohol Dependence journal shows that there has also been an increase in law enforcement seizures of psilocybin over the past few years as well. “We found that the number of shroom seizures and the total weight of shrooms seized annually increased through 2022, and the greatest weight of shrooms seized was in the West,” said study co-author Joseph J. Palamar told High Times. Out of 4,526 seizure reports between 2017-2022, the numbers increased from 402 in 2017, to 1,396 in 2022. While it’s clear that illegal mushroom cultivation and sales needs to be reduced in order to reduce access for adolescents and young adults, the legal psilocybin industry is struggling. Oregon’s psilocybin therapy treatment service program just passed its one-year mark, but has encountered challenges such as limited customers, partially due to high prices and advertising restrictions. Less than a year into its business, one psilocybin treatment center called The Journey has already closed up shop. Across the U.S., researchers continue to study psilocybin to determine its effectiveness as a treatment for many medical conditions. One study that was published in Clinical Case Reports earlier in June showed that both psilocybin and MDMA can be beneficial in treating symptoms of long-COVID, also called longhauler’s. Sufferers of this condition usually experience anxiety, depression, headaches, and struggles with cognition. Also in June, University of California, Berkeley announced that it will be embarking on a study to observe how psilocybin affects human perception. It’s the first psilocybin study that UC Berkeley is conducting using human subjects. “We have this incredible opportunity to characterize the psychedelic experience in real time—while it’s happening—using modern neuroimaging methods,” said UC Berkeley Center for the Science of Psychedelics director, Michael Silver. “Understanding the actions of psychedelics at a neuroscientific level will generate insights into how they’re working as medicines and will hopefully help us develop more effective treatments for mental health disorders. It will also shed light on some of the fundamental mysteries of the human brain, mind and consciousness and how they relate to each other.”

https://hightimes.com/

Study Explores Psilocybin for Anorexia, Rigid Thought Patterns

A new study examined the effects of psilocybin in an animal model for treating anorexia nervosa, showing that the compound improves body weight maintenance in female rats, facilitating what they call cognitive flexibility. Anorexia nervosa (AN) is deadly—having one of the highest mortality rates of any known psychiatric disease. It killed people such as Karen Carpenter of The Carpenters, or a list of famous models who dealt with unrealistic body goals. It affects women more often but also 10-15% of people with AN are male. The study, called “Psilocybin restrains activity-based anorexia in female rats by enhancing cognitive flexibility: contributions from 5-HT1A and 5-HT2A receptor mechanisms,”  was led by Dr. Claire Foldi of the Monash University Biomedicine Discovery Institute and published recently in the journal Molecular Psychiatry. People with eating disorders often suffer from symptoms like body dysmorphia and a poor self-image. These rigid thought patterns are difficult to overcome, and conventional medicine may not make much of a difference. Researchers observed a specific mechanism within the brain, allowing psilocybin to make “anorexic thinking” more pliable. Meanwhile, serotonin reuptake inhibitors, aka antidepressants, are the leading treatment, however they are used off-label and don’t appear to improve clinical symptoms in underweight people with anorexia, Foldi said. “Cognitive inflexibility is a hallmark of the condition often arising before symptoms of anorexia nervosa are obvious, and persisting after weight recovery—making this symptom a primary target for therapeutic intervention,” Foldi told MSN News. Researchers used young female rats in the study because they are particularly vulnerable to developing a particular ABA phenotype—a feature that is not fully understood but has been connected to the increased prevalence of AN in young women.  To test the effects of psilocybin on cognitive flexibility, saline or 5-HTR antagonists were administered 30 minutes prior to either saline or psilocybin treatment, at the completion of a training session. The following day the reward contingencies of the nose-poke ports were reversed, and rats underwent more testing. “Clinical trials evaluating the safety and efficacy of psilocybin in people with AN have been ongoing since 2019, with the first pilot study recently reporting that it improves eating disorder symptoms in some individuals, but not others. Psilocybin may have transdiagnostic efficacy through several mechanisms relevant to the pathology of AN, including actions on the serotonergic system and cognitive flexibility. However, the details of how such mechanisms are altered by psilocybin in the context of AN remains unknown.  The ABA paradigm, as they call it, involves unlimited access to a running wheel and time-restricted food access. At seven weeks of age, rats were individually housed in transparent living chambers with a removable food basket and a running wheel. They were given access to the wheel for seven days to determine baseline running wheel activity (RWA). The following day, psilocybin or saline was administered, wheels were locked for five hours and then it was reopened. Running activity was recorded electronically. “Here, we show that psilocybin improves body weight maintenance in the ABA rat model and enhances cognitive flexibility in a reversal learning task by both reducing perseverative responding and promoting task engagement when reward contingencies are initially reversed. That psilocybin did not elicit changes in motivated responding (PR) or response suppression (extinction) following the same training and drug administration protocol suggests a selective improvement in adaptive cognition in the face of changing rules.” Other studies linked psilocybin with eating disorders (EDs) like anorexia. Recently researchers Elena Koning and Elisa Brietzke explored the ways psilocybin can treat ED by its therapeutic benefits—also in combating rigid thought patterns. Koning, who is a doctoral student, recently wrote about her discoveries for PsyPost, explaining the reasoning behind her research. Koning mentioned that in the age of social media, EDs are becoming increasingly troublesome, and that new approaches to those types of disorders are needed. An earlier study, “Psilocybin-Assisted Psychotherapy as a Potential Treatment for Eating Disorders: a Narrative Review of Preliminary Evidence,” was published online ahead of print for Trends Psychiatry. “Eating disorders (ED) are a group of potentially severe mental disorders characterized by abnormal energy balance, cognitive dysfunction and emotional distress,” researchers wrote. “Cognitive inflexibility is a major challenge to successful ED treatment and dysregulated serotonergic function has been implicated in this symptomatic dimension. Moreover, there are few effective treatment options and long-term remission of ED symptoms is difficult to achieve. There is emerging evidence for the use of psychedelic-assisted psychotherapy for a range of mental disorders. Psilocybin is a serotonergic psychedelic which has demonstrated therapeutic benefit to a variety of psychiatric illnesses characterized by rigid thought patterns and treatment resistance.” The new study show’s psilocybin’s potential in the treatment of anorexia and other EDs.

https://hightimes.com/

Cheech and Chong Company To Hire a California Lobbyist

A company created by Cheech Marin and Tommy Chong—the iconic comedy duo known as Cheech and Chong—filed to hire a lobbyist in order to get involved with the lawmaking process in Sacramento, California.  Marin, 79, and Chong, 86, are moving their interests into California politics as it impacts businesses they own. CBS News reports that Cheech and Chong’s Global Holdings Company recently registered with the California Secretary of State. The company filed with the state of California on June 1 to register with Secretary of State Shirley M. Weber to hire a lobbyist. Cheech and Chong’s Global Holdings Company CEO Jonathan Black said the move is both about laws that impact hemp-derived product laws as well as laws that impact the cannabis industry in the state. “The reason why we hired a lobbyist is because there’s a bill—Assembly Bill 2223—that’s on the floor right now that regards intoxicating hemp products” Black tells High Times in a phone call. “We’ve had conversations with the CCIA [California Cannabis Industry Association]” Black said, describing the burdens of tax revenue that impacts hemp and cannabis, in comparison to other states like Illinois. AB 2223 would bring hemp-derived products into California’s state compliance system alongside cannabis products.  The 2018 Farm Bill legalized hemp and hemp-derived products, however, interest in active compounds like delta-8 led states to implement laws to either crack down on them or regulate them like cannabis in an age-gated system like you’d see for wine. “Ultimately we’ll continue to move the cannabis market in California forward,” he said, saying that they’re seeking an amendment that would provide wins for both the hemp and cannabis industries. “We hired a lobbyist, Kirk Hale from Aaron Reed & Associates, who’s a fantastic lobbyist doing great things for a long time to come,” Black says. “Right now if you look, there’s about 1,000 dispensary licenses in the state of California that are active but you have [around 200] paying taxes on time,” he says. Cheech and Chong’s Cannabis sells all types of terpene-based products ranging from concentrates to pre-rolls, gummies, and vapes. And they also sell hemp smokables. The Wild West days of Prop. 215 in California are over in the aftermath of adult-use cannabis. Today,  regulations and taxes are so burdensome they are forcing many cannabis businesses to close. One factor is the battle for hemp-derived products. In 2021, California Gov. Gavin Newsom signed Assembly Bill 45, establishing a comprehensive regulatory framework for the manufacture and sale of hemp-derived products in the state, including smokable hemp as well as hemp-infused food and drink sales. As an emergency statute, the bill goes into effect immediately. It allowed hemp-derived products like pre-rolls to thrive, as well as edibles and drinks, however dozens of states are in the process of regulating hemp or banning certain compounds from products. Assembly Bill 45 explicitly allows the sale of hemp-derived extracts that comply with testing and labeling standards. While CBD products are freely found in stores, they are considered “adulterated” under existing California law, which is defined under the Sherman Food, Drug, and Cosmetic Law. What AB-45 did is provide clarity for the hemp industry—more importantly, reassuring hemp consumers that products are independently tested and labeled properly. There are many other bills moving through Sacramento that impact cannabis and hemp businesses including the companies linked to Cheech and Chong. Marketing research firms BDSA Analytics and Headset both report that Michigan cannabis businesses sold more products than California’s industry. While California’s cannabis industry sales revenue remains a few billion higher than Michigan’s, cheaper prices in Michigan led to more units being sold in recent years. And it shouldn’t be happening for a state as large as California. Cheech and Chong’s company rebranded back in 2021. Eighth Icon Holdings announced in a press release that it changed its name to Cheech and Chong’s Cannabis Company, effective immediately. Consolidating the name with the comedy duo’s iconic brand aligns with the company’s mission. The company formerly known as Eighth Icon produces Tommy Chong’s Cannabis and Cheech’s Stash wholesale flower brands in California—with plans to continue that momentum. Being in operation for less than a year, the company recently redirected its website to Cheech And Chong’s Cannabis. “Our team is prepared for the challenge and committed to representing Cheech and Chong’s cannabis across the United States and around the world. This name change allows for clear representation of what our company is executing,” Black said. The company is also behind other various projects in past years such as Cheech and Chong’s Takeout, as well as Cheech and Chong’s Dispensoria—providing delivery experiences. Cheech and Chong’s Dispensoria was developed by Eight Icon last year, and Cheech and Chong’s Takeout was developed amid a sudden need for more delivery options during the pandemic. By the end of the month, Cheech and Chong Global Holdings is expected to file more paperwork with the state showing how much money they have spent and on exactly what issues in order to follow through with the plan.

https://hightimes.com/

California State Fair To Feature Weed Sales, Consumption Lounge

This year’s California State Fair will feature weed sales and a cannabis consumption area in the latest sign of marijuana’s growing acceptance by mainstream America. This year marks the first year that cannabis sales have been permitted at the event, which begins in Sacramento on July 12. The California State Fair welcomed weed to the festivities for the first time in 2022 with an exhibition and competition, much like many of the state’s famed agricultural products including wine, cheese, olive oil and craft beer. The pot-friendly events will be expanded this year, with a broadened marijuana products competition, a weed consumption lounge and onsite sales operated by licensed cannabis retailer and event concessionaire Embarc. “The California State Fair took a historic leadership position in 2022 with the introduction of a cannabis exhibit and competition,” Tom Martinez, CEO of the California State Fair, said in a statement. “This year, we’ve expanded our offerings to include onsite sales and consumption in a designated area to provide a platform to amplify California’s rich agricultural bounty and facilitate storytelling for farmers from diverse backgrounds and experiences.” This year will be the first time in the 170-year history of the California State Fair that cannabis sales and consumption will be allowed. The cannabis exhibition hall, which is restricted to adults aged 21 and up with government-issued identification, will include farm displays and educational information about California’s storied cannabis history.  Visitors will be able to scan QR codes to learn more about Golden Bear award winners, add cannabis products to a virtual shopping basket and purchase them at Embarc’s on-site dispensary. The area will feature a 30,000-square-foot consumption lounge, accessible via a designated walking path, to give attendees over the age of 21 an opportunity to try winning products from diverse farms and brands from throughout the state. “Hosting cannabis sales and consumption is a groundbreaking milestone in destigmatization by facilitating a deeper connection between consumers and the farmers who cultivate their products with such care,” said Lauren Carpenter, co-founder of Embarc. “Joining James Leitz, pioneer of the educational exhibit and competition for the past two years, on an expanded competition and experiential dispensary is a major step forward for responsible normalization.” Organizers of the event say that visitors to the onsite consumption area may be surprised by how the exhibit hall has been transformed for the event. “‘Designated smoking area’ is the required terminology,” Carpenter told the Los Angeles Times. “But that makes it sound like people standing around outside of a building smoking. This is intended to be experiential and fully built out and produced with a stage where we will have a ceremony for our [cannabis] award winners. [And] right now, our theme is ‘oasis’ — because, in case you missed it, it’s really hot in Sacramento — and our intention is to make this a respite.” “This initiative spotlights the significant role of cannabis in California’s agricultural industry, marking a major milestone in the state fair’s 170-year history,” said James Leitz, executive producer of the cannabis competition and exhibit. “Expanding the competition to include all form factors and providing patrons the opportunity to directly engage with and consume winning brands is transformational for public understanding of the plant.” The California State Fair kicks off on July 12 at the California Exposition Center in Sacramento and runs through July 28.

FAQ: How to use this hemp news hub

What topics does Chow420’s hemp news cover?

We aggregate and surface reputable coverage on hemp laws and enforcement, THC thresholds and policy proposals, cannabinoid products (CBD/Delta-8/hemp-derived THC), compliance, lab testing, recalls, and broader industry news.

Is this legal advice?

No. This page is for news and education. Hemp rules can change quickly and vary by state—always verify against the latest official guidance and consult qualified counsel for compliance decisions.

How do I evaluate hemp product safety claims?

Look for current third‑party COAs (Certificates of Analysis), clear ingredient labeling, and transparent sourcing. Be cautious with vague potency claims or missing lab reports.

Why do some articles mention Delta‑8 or “hemp-derived THC”?

These products often sit at the center of policy and enforcement changes. We track major updates so shoppers and brands can understand evolving requirements and market impacts.

How often is the news updated?

The crawler is scheduled to run daily. New items appear as sources publish updates.